查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1853447

體外震波碎石市場依技術、應用、最終用戶、便攜性和治療模式分類－2025-2032年全球預測

Extracorporeal Shock Wave Lithotripsy Market by Technology, Application, End User, Portability, Treatment Mode - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，體外震波碎石術市場規模將成長 6.0268 億美元，複合年成長率為 6.63%。

主要市場統計數據
基準年 2024 3.6048億美元
預計年份：2025年 3.8492億美元
預測年份：2032年 6.0268億美元
複合年成長率 (%) 6.63%

策略實施概述，介紹了體外震波碎石術的臨床效用、工作流程影響和決策標準框架，這些因素共同塑造了體外震波碎石術在當今的普及應用。

體外震波碎石術（ESWL）作為一種非侵入性碎石方法，在現代泌尿系統實踐中佔據核心地位，用於碎裂膽道和泌尿道結石。 ESWL的臨床意義在於其能夠將聚焦的聲能傳遞至結石，將其擊碎，同時最大限度地減少手術創傷，從而加快患者康復並減少醫療資源的消耗。近年來，隨著影像處理、衝擊波發生技術和人體工學的進步，ESWL已從一種純粹的院內手術發展成為一種可在門診手術中心和診所開展的多功能治療選擇。

臨床醫師和管理人員在評估體外震波碎石術（ESWL）時，不僅關注其臨床療效，還關注其與工作流程的整合、病患週轉率以及報銷機制。科技的改進提升了結石定位和能量傳遞的精準度，這些進步正在加速ESWL在傳統住院環境以外的場所的應用。因此，策略決策者在決定ESWL在其泌尿系統服務體系中的作用時，需要權衡臨床療效、資金投入和營運方面的考量。

本出版物為評估體外震波碎石術（ESWL）市場格局的相關人員提供了臨床和營運方面的背景資訊。後續章節將探討轉型轉變、收費標準影響、市場區隔考量、區域動態、競爭定位，並為尋求實現產品和服務持續成長和臨床影響力的產業領導者提供切實可行的建議。

技術進步、分散式治療模式和臨床管道最佳化如何重塑體外震波碎石術的格局

體外震波碎石術（ESWL）領域正經歷著一場變革性的轉變，這主要得益於技術、臨床和操作等多面向因素的融合。電液、電磁和壓電等衝擊波發生技術的創新正在最佳化能量輸出和延長設備使用壽命，而整合成像和即時回饋技術的進步則提高了靶向精度和臨床療效。同時，設備便攜性的提升模糊了固定式醫院系統和適用於門診的行動裝置之間的界限，從而催生了新的醫療服務模式，並擴大了社區中心的覆蓋範圍。

臨床路徑也在不斷發展，更加重視門診治療模式和通訊協定，以減輕住院患者的負擔。無論是獨立的還是醫院附屬的日間手術中心，都配備了更完善的設備，能夠安全高效地提供體外震波碎石術（ESWL）；泌尿系統專科診所和多專科診所也在積極拓展服務範圍。同時，圍手術全期護理和病患篩選流程也得到了改進，從而提高了病患滿意度，並降低了整個醫療系統的成本。

同時，監管和設備生命週期管理促使製造商優先考慮安全性、易用性和可維護性。結果數據和真實世界證據正被用於凸顯產品價值提案，臨床醫生、設備製造商和支付方之間的合作模式也正在興起，以解決報銷和准入障礙。總而言之，這些趨勢表明，體外震波碎石術（ESWL）的治療模式正朝著以患者為中心、去中心化和技術主導的方向轉變。

新關稅動態對體外震波碎石術生態系統供應鏈策略、採購實務和總成本考量的影響

2025年關稅政策為醫療設備系統中的供應鏈韌性、籌資策略和產品定價帶來了新的考量。面對進口零件成本的不斷上漲，製造商評估了多種方案，例如關鍵次組件的垂直整合、策略性庫存以及製造地的選擇性地域多元化，以減輕關稅的影響。同時，服務機構重新審視了備件庫存和維護契約，力求在不給臨床客戶造成過重成本負擔的前提下，確保設備的正常運行運作。

醫療服務提供者和採購集團的應對措施是，更加嚴格地審查總體擁有成本，並優先考慮那些維護週期更長、提供本地技術支援且零件通用更高的設備。因此，採購談判越來越強調配套服務安排和基於性能的保修，從而將獎勵與設備性能掛鉤。對於一些市場參與企業，關稅加速了關於近岸外包和與本地供應商合作的討論，以穩定供應鏈並縮短前置作業時間。

重要的是，這些調整輔以對物流可視性和風險建模工具的更多投資。雖然關稅改變了成本構成和合約結構，但也促使製造策略和供應商合作方面出現切實可行的創新，從而能夠提高體外衝擊波碎石（ESWL）價值鏈的長期可靠性和應對力。

詳細的細分洞察揭示了技術類型、臨床用途、使用者環境、便攜性和治療模式如何決定產品定位和採用管道。

細分市場分析突顯了技術偏好、臨床應用、使用者環境、便攜性要求和治療模式等方面的顯著差異，這些差異共同影響著產品設計和市場推廣策略。電液、電磁和壓電系統之間的技術選擇不僅影響聚焦精度和能量分佈等臨床性能特徵，還影響可維護性、運行噪音和資本支出。這些差異指南著醫院系統、門診手術中心和診所的決策，幫助他們將設備功能與手術量和治療目標相匹配。

膽囊結石、腎結石和輸尿管結石的應用細分凸顯了與結石成分、大小分佈和解剖位置相關的臨床需求差異。針對腎結石最佳化的設備可能優先考慮更深的局部穿透和可調控的能量分佈，而用於輸尿管結石碎片的系統則需要快速定位並與輔助顯像模式方式整合。門診手術中心（包括獨立門診和醫院附屬門診）優先考慮的是吞吐量和周轉率；診所（包括多專科診所和泌尿系統診所）優先考慮的是易用性和空間利用率；而醫院（包括私立醫院和公立醫院）則需要強大的服務支援和符合監管要求。便攜性偏好（分為便於推廣的可攜式系統和可容納大量患者的固定式系統）會影響部署要求和市場推廣策略。

治療方式的選擇，即住院或門診病人，會進一步影響設備功能、服務合約和報銷機制之間的相互作用。門診病人手術優先考慮簡化患者流程和減少麻醉需求，而住院手術則強調全面的手術全期整合和處理複雜病例的能力。這些細分洞察為相關人員之間的產品定位和商業性優先排序提供了一個細緻的框架。

區域監管差異、醫療基礎設施成熟度和服務網路結構導致體外震波碎石技術的應用策略各不相同。

區域動態受制於不同的法規環境、醫療服務基礎設施和支付體系，進而影響醫療設備的採用管道和競爭策略。在美洲，先進的臨床中心和廣泛的門診手術網路集中分佈，使得醫療設備對兼顧性能和易維護性的需求日益成長；而報銷政策和融資週期則影響著醫療設備的採用時機。清晰的監管政策和成熟的技術服務生態系統為下一代系統的應用提供了支持，醫療服務提供者也越來越傾向於尋求能夠簡化患者就診流程和文件記錄的整合解決方案。

西歐成熟的醫療體系強調實證實踐和預算課責，而該地區的新興市場則優先考慮成本效益高的技術和可擴展的服務模式。法律規範各不相同，市場參與企業受益於本地臨床夥伴關係和能夠反映支付方多樣性的適應性商業模式。在亞太地區，門診容量的快速擴張、醫療基礎設施的投資以及臨床專業化的日益普及，推動了對固定式高通量系統和移動式設備的需求，以服務於地理位置分散的人群。本地製造夥伴關係和售後服務網路在加速技術應用和增強臨床醫生信心方面發揮著重要作用。

對於希望調整監管策略、定價策略和分銷模式以適應各地區醫療服務和報銷實際情況的公司而言，了解這些區域差異至關重要。在從區域分析過渡到戰術性規劃的過程中，相關人員應優先考慮監管協調、服務網路建設和臨床醫生參與，以掌握各個市場的機會。

競爭和服務生態系統分析表明，設備差異化、臨床夥伴關係和售後支援將決定市場定位和採購結果。

體外震波碎石術（ESWL）領域的競爭格局由傳統企業、創新型參與企業和專業服務供應商組成，各方都在臨床療效、設備可靠性和售後服務支援方面展開競爭。大型製造商致力於透過衝擊波生成和影像整合技術的進步來打造差異化產品，同時投資於培訓和技術支持，以減少臨床團隊的操作阻力。新參與企業和小型供應商則著重於細分市場，例如可攜式系統和針對門診和診所環境量身定做的具成本效益機型，並力求透過極具吸引力的整體價值提案來顛覆現有的購買模式。

服務機構和第三方維護供應商發揮策略性作用，尤其是在本地技術能力有限的地區。製造商與本地分銷商之間的夥伴關係對於擴大產品覆蓋範圍和確保零件快速供應至關重要，這反過來又會影響醫院和診所的偏好。設備製造商與臨床專家之間的策略合作也影響產品藍圖的製定，真實世界的證據和臨床醫生的回饋推動著使用者介面、標靶精確度、病患舒適度等方面的迭代改進。

從商業性角度來看，差異化越來越依賴可驗證的成果、易於整合到現有工作流程中以及可預測的生命週期成本。能夠將可靠的臨床證據、響應迅速的服務網路以及靈活的資金籌措和採購模式相結合的公司，將更有利於贏得採購競爭，並在不同的醫療保健環境中擴大其客戶群。

為製造商和供應商提供切實可行的優先建議，以幫助他們調整產品設計、服務模式和證據生成，從而滿足不同的臨床和地理需求。

為了掌握體外震波碎石術（ESWL）領域的新機遇，產業領導者應採取多管齊下的策略，協調技術開發、商業模式和臨床醫生參與。首先，應優先考慮設備的模組化和互通性，使系統能夠升級以適應不斷發展的影像處理和靶向功能，而無需徹底更換，從而減少醫院和診所客戶在整個生命週期中的中斷，並支持長期合作關係。其次，應設計能夠反映終端用戶多樣性的定價和服務組合——包括門診手術中心、多專科診所、泌尿系統診所以及公立和私立醫院——並製定可擴展的契約，以適應不僅固定場所的高通量系統，而且獨立和醫院附屬的門診單元。

第三，投資本地服務基礎設施和夥伴關係，以縮短維護和備件回應時間。第四，發展並傳播可靠的真實世界證據，以支持臨床醫生採納相關技術並就膽結石、腎結石和輸尿管結石等應用進行報銷談判。第五，評估供應鏈彈性措施，例如多元化採購和近岸外包，以降低海關和物流風險，同時維持品質標準。透過按順序實施這些舉措並將其與有針對性的區域策略相結合，企業可以建立永續的競爭優勢並贏得臨床醫生的信任。

最後，促進臨床醫生培訓計劃和協作測試計劃，以證明營運效率和患者療效，不僅可以加速推廣，還可以培養倡導者，幫助應對醫療保健採購流程和與支付方的談判。

採用透明的混合方法研究途徑，結合臨床文獻、監管分析、技術評估和相關人員訪談，以獲得實證的策略性洞見。

這項分析研究結合了近期同行評審的臨床文獻、監管文件、產品技術文件以及對臨床專家、採購負責人和設備工程師的結構化訪談。調查方法強調三角驗證。將定性專家見解與設備規格和服務記錄進行交叉檢驗，以確保對技術性能、維護概況和臨床工作流程的解讀準確可靠。此外，還探討了區域監管指南和公共報銷框架，以指導市場准入考量並識別實際應用障礙。

主要研究包括與不同醫療機構的臨床醫生進行訪談，這些機構包括醫院住院部、獨立和醫院附屬的門診手術中心、多學科診療中心以及泌尿系統專科診療中心，旨在收集他們對設備可用性、患者選擇以及融入診療路徑等方面的不同觀點。技術評估考慮了電液式、電磁式和壓電技術之間的差異，以及攜帶式和固定式設備在便攜便攜性方面的差異。此外，也納入了供應鏈和採購的觀點，以反映關稅影響和物流的因素。

研究結果綜合提煉為主題洞見，為市場區隔、區域動態、競爭定位和可執行建議提供了依據。在整個研究過程中，我們始終注意區分臨床證據和商業性宣傳，並記錄策略意義背後的基本假設。

簡要總結了將技術進步、營運重點和當地實際情況與擴大體外震波碎石術應用範圍的策略要務聯繫起來的結論。

總之，體外震波碎石術仍然是非侵入性結石治療的重要技術，其未來發展將受到技術進步、分散式醫療模式和務實商業策略的影響。電液、電磁和壓電系統的進步，以及影像整合和便攜性的提升，正在拓展體外震波碎石術安全有效應用的領域。同時，門診病人通路設計、服務可近性和供應鏈彈性等營運要素正在影響採購決策，並塑造競爭優勢。

區域差異凸顯了量身訂做方案的重要性，該方案需反映各個市場（美洲、中東和非洲以及亞太地區）的法規環境、支付方結構和本地技術能力。將可驗證的臨床結果與可靠的服務網路和靈活的商業模式相結合，以滿足門診手術中心、診所和醫院的需求，從而創造競爭優勢。將臨床結果轉化為可預測的營運績效和可控的生命週期成本，使相關人員能夠支援體外震波碎石術（ESWL）的廣泛應用，同時使產品和服務策略與醫療保健系統的優先事項保持一致。

最終，前進的方向是透過對技術、證據產生和區域夥伴關係的共同投資，在不同的醫療保健環境中實現以患者為中心、可擴展的體外碎石服務。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 體外震波碎石系統整合了即時超音波和透視影像放大技術，以精確定位結石位置。
  • 開發攜帶式、電池供電的體外震波碎石機，用於偏遠地區的泌尿系統照護現場治療
  • 體外震波碎石術與超音波碎石術結合，能夠更快、更徹底地清除腎結石。
  • 機器學習演算法在個人化體外震波碎石治療計畫和能量調整的應用日益廣泛
  • 可重複使用模組化衝擊波發生裝置的推廣應用，降低了大型衝擊波治療中心的運作成本和廢棄物。
  • 患者特異性3D列印耦合墊片的出現最佳化了震波的傳遞，並減少了體外震波碎石術過程中的組織損傷。
  • 泌尿系統設備製造商和軟體分析供應商合作推出整合式體外碎石術療效追蹤平台
  • 遠端醫療的遠端監測解決方案在體外震波碎石術後患者復健評估和後續照護的廣泛應用

第6章美國關稅的累積影響，2025年

第7章 人工智慧的累積影響，2025年

8. 體外震波碎石術市場（依技術分類）

  • 電液式
  • 電磁
  • 壓電

第9章 體外震波碎石術市場（依應用領域分類）

  • 膽結石
  • 腎結石
  • 輸尿管結石

第10章 體外震波碎石術市場（依最終用戶分類）

  • 門診手術中心
    • 獨立中心
    • 醫院附設中心
  • 診所
    • 多學科診所
    • 泌尿系統診所
  • 醫院
    • 私立醫院
    • 公立醫院

第11章 體外震波碎石術市場（依移動類型分類）

  • 移動的
  • 固定式

第12章 體外震波碎石市場依治療模式分類

  • 住院治療
  • 門診

第13章 體外震波碎石術市場（依地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 體外震波碎石市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國體外震波碎石市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Siemens Healthineers AG
    • Olympus Corporation
    • Dornier MedTech GmbH
    • EDAP TMS SA
    • Storz Medical AG
    • Richard Wolf GmbH
    • EMS Electro Medical Systems SA
    • Beijing Well Medical Technology Co., Ltd.
    • Medstone International Urology Pvt. Ltd.
    • Chongqing Haifu Ultrasound Technology Co., Ltd.
Product Code: MRR-3A2E844FE771

The Extracorporeal Shock Wave Lithotripsy Market is projected to grow by USD 602.68 million at a CAGR of 6.63% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 360.48 million
Estimated Year [2025] USD 384.92 million
Forecast Year [2032] USD 602.68 million
CAGR (%) 6.63%

A strategic introductory overview that frames clinical utility, workflow implications, and decision criteria shaping contemporary extracorporeal shock wave lithotripsy adoption

Extracorporeal shock wave lithotripsy (ESWL) occupies a central role in contemporary urological care as a noninvasive modality for fragmenting calculi across the biliary and urinary tracts. Its clinical relevance is rooted in the ability to deliver focused acoustic energy to disrupt stones while minimizing surgical trauma, enabling faster recovery and reduced hospital resource utilization. Over recent years, ESWL has evolved from a purely hospital-based intervention to a versatile therapeutic option used across ambulatory surgical centers and clinics, supported by improvements in imaging, shock wave generation, and device ergonomics.

Clinicians and administrators alike are evaluating ESWL not only through clinical efficacy but also through workflow integration, patient throughput, and reimbursement dynamics. Technological refinements have improved stone localization and energy delivery, and these enhancements have accelerated adoption in settings beyond traditional inpatient units. Consequently, strategic decision-makers are balancing clinical outcomes, capital allocation, and operational considerations as they determine the role of ESWL within urology service lines.

This introduction establishes the clinical and operational context for stakeholders assessing the ESWL landscape. It lays the groundwork for sections that follow, which examine transformational shifts, tariff implications, segmentation insights, regional dynamics, competitive positioning, and practical recommendations for industry leaders seeking to position products and services for sustainable growth and clinical impact.

How converging technological refinements, decentralized delivery models, and clinical pathway optimization are reshaping the extracorporeal shock wave lithotripsy landscape

The ESWL landscape is undergoing transformative shifts driven by converging technological, clinical, and operational forces. Innovations in shock wave generation-spanning electrohydraulic, electromagnetic, and piezoelectric approaches-are optimizing energy delivery and device longevity, while advances in integrated imaging and real-time feedback are improving targeting accuracy and clinical outcomes. Parallel developments in portability have blurred the lines between stationary, hospital-based systems and mobile units suited to ambulatory environments, thereby enabling new care delivery models and extending access to community-based centers.

Clinical pathways are also evolving, with greater emphasis on outpatient treatment models and protocols that reduce inpatient burden. Ambulatory surgical centers, including both freestanding and hospital-based centers, are increasingly positioned to deliver ESWL safely and efficiently, and multispecialty clinics as well as urology-focused clinics are exploring service expansions. These shifts are accompanied by refinements in perioperative care and patient selection that enhance patient satisfaction and lower overall system costs.

Concurrently, regulatory scrutiny and device lifecycle management are prompting manufacturers to prioritize safety features, ease of use, and serviceability. Outcomes data and real-world evidence are being deployed to differentiate product value propositions, while collaborative models between clinicians, device makers, and payers are emerging to address reimbursement and access barriers. Taken together, these trends signal a transition toward more patient-centric, decentralized, and technology-driven ESWL care paradigms.

Impacts of new tariff dynamics on supply chain strategies, procurement practices, and total cost considerations within the extracorporeal shock wave lithotripsy ecosystem

The imposition of tariffs in 2025 introduced new considerations for supply chain resiliency, procurement strategy, and product pricing within the medical device ecosystem, and ESWL stakeholders are navigating these pressures with a mix of operational and commercial responses. Manufacturers faced with increased costs for imported components evaluated options including vertical integration of key subassemblies, strategic stockpiling, and selective geographic diversification of manufacturing footprints to mitigate exposure. In parallel, service organizations reexamined spare parts inventories and maintenance contracts to sustain uptime without passing disproportionate cost burdens to clinical customers.

Healthcare providers and purchasing groups reacted by intensifying scrutiny on total cost of ownership, prioritizing devices that offered longer service intervals, local technical support, and parts commonality across installed bases. As a result, procurement negotiations began to emphasize bundled service arrangements and outcome-based warranties that align maintenance incentives with device performance. For some market participants, tariffs accelerated conversations about nearshoring and partnerships with regional suppliers to stabilize supply chains and reduce lead times.

Importantly, these adaptations were complemented by increased investment in logistics visibility and risk modeling tools, which helped organizations anticipate disruptions and plan mitigations. While tariffs altered cost equations and contractual structures, they also prompted practical innovations in manufacturing strategy and supplier collaboration that can enhance long-term reliability and responsiveness across the ESWL value chain.

Detailed segmentation insights revealing how technology type, clinical application, user environment, portability, and treatment mode define product positioning and adoption pathways

Segment analysis highlights meaningful distinctions in technology preferences, clinical applications, user settings, portability requirements, and treatment modes that collectively shape product design and go-to-market strategies. Technology choice between electrohydraulic, electromagnetic, and piezoelectric systems influences not only clinical performance characteristics such as focal precision and energy dispersion but also serviceability, operating noise, and capital expenditure profiles. These differences guide decisions by hospital systems, ambulatory surgical centers, and clinics when aligning device capabilities with procedural volumes and care objectives.

Application segmentation between gallbladder stones, renal calculi, and ureteral calculi underscores divergent clinical requirements related to stone composition, size distribution, and anatomical access. Devices optimized for renal calculi may prioritize deeper focal penetration and adjustable energy profiles, while systems used for ureteral fragments require rapid targeting and integration with auxiliary imaging modalities. End-user diversity is significant: ambulatory surgical centers, both freestanding and hospital-based, emphasize throughput and rapid turnover; clinics, including multispecialty and urology clinics, prioritize ease of use and space efficiency; and hospitals, whether private or public, demand robust service support and regulatory compliance. Portability preferences split between mobile units that enable outreach and stationary systems that anchor high-volume centers, affecting installation requirements and marketing narratives.

Treatment mode considerations-namely inpatient versus outpatient pathways-further influence device feature sets, service contracts, and reimbursement interactions. Outpatient procedures prioritize streamlined patient flow and minimal anesthesia requirements, while inpatient settings focus on comprehensive perioperative integration and complex case capabilities. Taken together, these segmentation insights provide a nuanced framework for product positioning and commercial prioritization across stakeholder cohorts.

How regional regulatory variability, care infrastructure maturity, and service networks drive differentiated adoption strategies for extracorporeal shock wave lithotripsy technologies

Regional dynamics are shaped by diverse regulatory environments, care delivery infrastructures, and payer systems that affect adoption pathways and competitive strategies. In the Americas, a concentration of advanced clinical centers and extensive ambulatory surgical networks creates demand for devices that balance performance with serviceability, while reimbursement policies and capital procurement cycles influence adoption timing. Regulatory clarity and established technical service ecosystems support the introduction of next-generation systems, and providers increasingly seek integrated solutions that streamline patient throughput and documentation.

Across Europe, the Middle East & Africa, the landscape is heterogeneous: mature Western European systems emphasize evidence-based adoption and budgetary accountability, while emerging markets in the region prioritize cost-effective technologies and scalable service models. Regulatory frameworks vary, and market entrants benefit from localized clinical partnerships and adaptable commercial models that reflect payer diversity. In the Asia-Pacific region, rapid expansion of ambulatory capacity, investments in healthcare infrastructure, and growing clinical expertise are driving demand for both stationary high-throughput systems and mobile units that serve geographically dispersed populations. Local manufacturing partnerships and responsive after-sales networks play an outsized role in accelerating adoption and building clinician confidence.

Understanding these regional nuances is essential for companies seeking to tailor regulatory strategies, pricing approaches, and distribution models that align with local healthcare delivery and reimbursement realities. Transitioning from regional analysis to tactical planning, stakeholders should prioritize regulatory alignment, service network development, and clinician engagement to capture opportunities across varied markets.

Competitive and service ecosystem analysis showing how device differentiation, clinical partnerships, and after-sales support determine market positioning and procurement outcomes

Competitive dynamics in the ESWL sector reflect a mix of legacy incumbents, innovative entrants, and specialized service providers, each competing on clinical performance, device reliability, and after-sales support. Leading manufacturers maintain emphasis on product differentiation through advances in shock wave generation and imaging integration, while simultaneously investing in training and technical support that reduce operational friction for clinical teams. New entrants and smaller suppliers focus on niche opportunities, such as portable systems or cost-effective models tailored to ambulatory and clinic settings, seeking to disrupt established purchasing patterns with compelling total-value propositions.

Service organizations and third-party maintenance providers play a strategic role, particularly in regions where local technical capacity is limited. Partnerships between manufacturers and regional distributors are instrumental for scaling access and ensuring rapid parts availability, which in turn affects hospital and clinic preferences. Strategic collaborations between device makers and clinical champions are also shaping product roadmaps, with real-world evidence and clinician feedback driving iterative improvements in user interfaces, targeting accuracy, and patient comfort.

From a commercial perspective, differentiation increasingly hinges on demonstrable outcomes, ease of integration into existing workflows, and predictable lifecycle costs. Companies that can combine robust clinical evidence, responsive service networks, and adaptable financing or procurement models are best positioned to win procurement discussions and to expand installed bases across diverse care settings.

Practical and prioritized recommendations for manufacturers and providers to align product design, service models, and evidence generation with varied clinical and regional demands

Industry leaders should adopt a multi-pronged approach that aligns technology development, commercial models, and clinician engagement to capture emerging opportunities in ESWL. First, prioritize device modularity and interoperability so that systems can be upgraded with evolving imaging and targeting capabilities without requiring full replacement; this reduces total lifecycle disruption for hospital and clinic customers and supports long-term relationships. Second, design pricing and service bundles that reflect the diversity of end users-ambulatory surgical centers, multispecialty clinics, urology clinics, and both private and public hospitals-by offering scalable contracts that accommodate freestanding and hospital-based ambulatory units as well as stationary high-throughput systems.

Third, invest in regional service infrastructure and partnerships to shorten response times for maintenance and spare parts, which is particularly important in markets where local technical capacity is variable. Fourth, generate and disseminate robust real-world evidence across applications such as gallbladder stones, renal calculi, and ureteral calculi to support clinician adoption and reimbursement dialogues. Fifth, evaluate supply chain resilience measures-such as diversified sourcing and nearshoring-that mitigate tariff and logistics risks while maintaining quality standards. By sequencing these initiatives and aligning them with targeted regional strategies, companies can build durable competitive advantage and foster clinician trust.

Finally, foster clinician training programs and collaborative pilots that demonstrate operational efficiencies and patient outcomes; these initiatives not only accelerate adoption but also create advocates who help navigate institutional procurement processes and payer negotiations.

Transparent mixed-methods research approach combining clinical literature, regulatory analysis, technical review, and stakeholder interviews to produce evidence-based strategic insights

Research for this analysis combined a review of recent peer-reviewed clinical literature, regulatory filings, product technical documentation, and structured interviews with clinical specialists, procurement executives, and device engineers. The methodology emphasized triangulation: qualitative insights from domain experts were cross-validated with device specifications and service records to ensure robust interpretation of technology performance, maintenance profiles, and clinical workflows. Additionally, regional regulatory guidance and public reimbursement frameworks were examined to inform market access considerations and to identify practical barriers to adoption.

Primary research included discussions with clinicians across care settings-hospital inpatient units, ambulatory surgical centers both freestanding and hospital-based, multispecialty clinics, and specialized urology clinics-to capture diverse perspectives on device usability, patient selection, and integration into care pathways. Technical assessments considered differences across electrohydraulic, electromagnetic, and piezoelectric systems, as well as portability characteristics between mobile and stationary platforms. Supply chain and procurement perspectives were incorporated to reflect tariff impacts and logistics considerations.

Findings were synthesized into thematic insights that inform segmentation, regional dynamics, competitive positioning, and actionable recommendations. Throughout the research process, care was taken to separate clinical evidence from commercial assertions and to document assumptions underlying strategic implications.

Concise concluding synthesis linking technological evolution, operational priorities, and regional realities to the strategic imperatives for expanding extracorporeal shock wave lithotripsy access

In conclusion, extracorporeal shock wave lithotripsy remains a pivotal technology for noninvasive stone management, and its future trajectory will be shaped by technology refinement, decentralized care models, and pragmatic commercial strategies. Advances across electrohydraulic, electromagnetic, and piezoelectric systems, together with improvements in imaging integration and portability, are expanding the contexts in which ESWL can be delivered safely and effectively. Meanwhile, operational imperatives-such as outpatient pathway design, serviceability, and supply chain resilience-are influencing procurement decisions and shaping competitive differentiation.

Regional nuances underscore the importance of tailored approaches that reflect regulatory environments, payer structures, and local technical capabilities across the Americas, Europe Middle East & Africa, and Asia-Pacific markets. Competitive advantage will accrue to organizations that combine demonstrable clinical outcomes with reliable service networks and flexible commercial models that address the needs of ambulatory surgical centers, clinics, and hospitals. By translating clinical efficacy into predictable operational performance and manageable lifecycle costs, stakeholders can support broader access to ESWL while aligning product and service strategies with healthcare system priorities.

Ultimately, the path forward involves coordinated investments in technology, evidence generation, and regional partnerships that together enable scalable, patient-centered lithotripsy services across diverse care settings.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of real-time ultrasound and fluoroscopic imaging enhancements into shock wave lithotripsy systems for precise stone localization
  • 5.2. Development of portable and battery-powered shock wave lithotripsy devices enabling point-of-care urological treatments in remote settings
  • 5.3. Advancement of combined shock wave lithotripsy and ultrasonic fragmentation techniques for faster and more complete renal stone clearance
  • 5.4. Rising adoption of machine learning algorithms for personalized shock wave lithotripsy treatment planning and energy modulation
  • 5.5. Expansion of reusable and modular shock wave generation units to lower operating costs and environmental waste in high-volume centers
  • 5.6. Emergence of patient-specific 3D-printed coupling pads to optimize shock wave transmission and reduce tissue trauma during lithotripsy
  • 5.7. Collaboration between urology device manufacturers and software analytics providers to deliver integrated lithotripsy outcome tracking platforms
  • 5.8. Introduction of adaptive energy dosing protocols in shock wave lithotripsy to minimize soft tissue injury in complex stone cases
  • 5.9. Surge in telemedicine-enabled remote monitoring solutions for post-lithotripsy patient recovery assessment and follow-up care

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Extracorporeal Shock Wave Lithotripsy Market, by Technology

  • 8.1. Electrohydraulic
  • 8.2. Electromagnetic
  • 8.3. Piezoelectric

9. Extracorporeal Shock Wave Lithotripsy Market, by Application

  • 9.1. Gallbladder Stones
  • 9.2. Renal Calculi
  • 9.3. Ureteral Calculi

10. Extracorporeal Shock Wave Lithotripsy Market, by End User

  • 10.1. Ambulatory Surgical Centers
    • 10.1.1. Freestanding Centers
    • 10.1.2. Hospital Based Centers
  • 10.2. Clinics
    • 10.2.1. Multispecialty Clinics
    • 10.2.2. Urology Clinics
  • 10.3. Hospitals
    • 10.3.1. Private Hospitals
    • 10.3.2. Public Hospitals

11. Extracorporeal Shock Wave Lithotripsy Market, by Portability

  • 11.1. Mobile
  • 11.2. Stationary

12. Extracorporeal Shock Wave Lithotripsy Market, by Treatment Mode

  • 12.1. Inpatient
  • 12.2. Outpatient

13. Extracorporeal Shock Wave Lithotripsy Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Extracorporeal Shock Wave Lithotripsy Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Extracorporeal Shock Wave Lithotripsy Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Siemens Healthineers AG
    • 16.3.2. Olympus Corporation
    • 16.3.3. Dornier MedTech GmbH
    • 16.3.4. EDAP TMS SA
    • 16.3.5. Storz Medical AG
    • 16.3.6. Richard Wolf GmbH
    • 16.3.7. EMS Electro Medical Systems SA
    • 16.3.8. Beijing Well Medical Technology Co., Ltd.
    • 16.3.9. Medstone International Urology Pvt. Ltd.
    • 16.3.10. Chongqing Haifu Ultrasound Technology Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY ELECTROHYDRAULIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY ELECTROHYDRAULIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY ELECTROHYDRAULIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY ELECTROHYDRAULIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY ELECTROHYDRAULIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY ELECTROHYDRAULIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY ELECTROMAGNETIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY ELECTROMAGNETIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY ELECTROMAGNETIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY ELECTROMAGNETIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY ELECTROMAGNETIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY ELECTROMAGNETIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PIEZOELECTRIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PIEZOELECTRIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PIEZOELECTRIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PIEZOELECTRIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PIEZOELECTRIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PIEZOELECTRIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY GALLBLADDER STONES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY GALLBLADDER STONES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY GALLBLADDER STONES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY GALLBLADDER STONES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY GALLBLADDER STONES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY GALLBLADDER STONES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY RENAL CALCULI, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY RENAL CALCULI, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY RENAL CALCULI, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY RENAL CALCULI, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY RENAL CALCULI, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY RENAL CALCULI, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY URETERAL CALCULI, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY URETERAL CALCULI, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY URETERAL CALCULI, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY URETERAL CALCULI, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY URETERAL CALCULI, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY URETERAL CALCULI, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY FREESTANDING CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY FREESTANDING CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY FREESTANDING CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY FREESTANDING CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY FREESTANDING CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY FREESTANDING CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITAL BASED CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITAL BASED CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITAL BASED CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITAL BASED CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITAL BASED CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITAL BASED CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY MULTISPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY MULTISPECIALTY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY MULTISPECIALTY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY MULTISPECIALTY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY MULTISPECIALTY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY MULTISPECIALTY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY UROLOGY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY UROLOGY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY UROLOGY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY UROLOGY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY UROLOGY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY UROLOGY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY MOBILE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY MOBILE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY MOBILE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY MOBILE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY MOBILE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY MOBILE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY STATIONARY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY STATIONARY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY STATIONARY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY STATIONARY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY STATIONARY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY STATIONARY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY INPATIENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY INPATIENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY INPATIENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY INPATIENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY INPATIENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY INPATIENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY OUTPATIENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY OUTPATIENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY OUTPATIENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY OUTPATIENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY OUTPATIENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY OUTPATIENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. AMERICAS EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 138. AMERICAS EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 139. AMERICAS EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 140. AMERICAS EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 141. AMERICAS EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 142. AMERICAS EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 143. AMERICAS EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 144. AMERICAS EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 145. AMERICAS EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
  • TABLE 146. AMERICAS EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2032 (USD MILLION)
  • TABLE 147. AMERICAS EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 148. AMERICAS EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 149. AMERICAS EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 150. AMERICAS EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 151. AMERICAS EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2024 (USD MILLION)
  • TABLE 152. AMERICAS EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2025-2032 (USD MILLION)
  • TABLE 153. AMERICAS EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2024 (USD MILLION)
  • TABLE 154. AMERICAS EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2025-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. NORTH AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 158. NORTH AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 160. NORTH AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 161. NORTH AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 162. NORTH AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 163. NORTH AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
  • TABLE 164. NORTH AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2032 (USD MILLION)
  • TABLE 165. NORTH AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 166. NORTH AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 167. NORTH AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 168. NORTH AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 169. NORTH AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2024 (USD MILLION)
  • TABLE 170. NORTH AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2025-2032 (USD MILLION)
  • TABLE 171. NORTH AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2024 (USD MILLION)
  • TABLE 172. NORTH AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2025-2032 (USD MILLION)
  • TABLE 173. LATIN AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. LATIN AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. LATIN AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 176. LATIN AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 177. LATIN AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 178. LATIN AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 179. LATIN AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 180. LATIN AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 181. LATIN AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
  • TABLE 182. LATIN AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2032 (USD MILLION)
  • TABLE 183. LATIN AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 184. LATIN AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 185. LATIN AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 186. LATIN AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 187. LATIN AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2024 (USD MILLION)
  • TABLE 188. LATIN AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2025-2032 (USD MILLION)
  • TABLE 189. LATIN AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2024 (USD MILLION)
  • TABLE 190. LATIN AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2025-2032 (USD MILLION)
  • TABLE 191. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 192. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 193. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 194. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 195. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 196. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2032 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2024 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2025-2032 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2024 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2025-2032 (USD MILLION)
  • TABLE 209. EUROPE EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. EUROPE EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. EUROPE EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 212. EUROPE EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 213. EUROPE EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 214. EUROPE EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 215. EUROPE EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 216. EUROPE EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 217. EUROPE EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
  • TABLE 218. EUROPE EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2032 (USD MILLION)
  • TABLE 219. EUROPE EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 220. EUROPE EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 221. EUROPE EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 222. EUROPE EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 223. EUROPE EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2024 (USD MILLION)
  • TABLE 224. EUROPE EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2025-2032 (USD MILLION)
  • TABLE 225. EUROPE EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2024 (USD MILLION)
  • TABLE 226. EUROPE EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2025-2032 (USD MILLION)
  • TABLE 227. MIDDLE EAST EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 228. MIDDLE EAST EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 229. MIDDLE EAST EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 230. MIDDLE EAST EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 231. MIDDLE EAST EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 232. MIDDLE EAST EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 233. MIDDLE EAST EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 234. MIDDLE EAST EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 235. MIDDLE EAST EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
  • TABLE 236. MIDDLE EAST EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2032 (USD MILLION)
  • TABLE 237. MIDDLE EAST EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 238. MIDDLE EAST EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 239. MIDDLE EAST EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 240. MIDDLE EAST EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 241. MIDDLE EAST EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2024 (USD MILLION)
  • TABLE 242. MIDDLE EAST EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2025-2032 (USD MILLION)
  • TABLE 243. MIDDLE EAST EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2024 (USD MILLION)
  • TABLE 244. MIDDLE EAST EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2025-2032 (USD MILLION)
  • TABLE 245. AFRICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 246. AFRICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 247. AFRICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 248. AFRICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 249. AFRICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 250. AFRICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 251. AFRICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 252. AFRICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 253. AFRICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
  • TABLE 254. AFRICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2032 (USD MILLION)
  • TABLE 255. AFRICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 256. AFRICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 257. AFRICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 258. AFRICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 259. AFRICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2024 (USD MILLION)
  • TABLE 260. AFRICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2025-2032 (USD MILLION)
  • TABLE 261. AFRICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2024 (USD MILLION)
  • TABLE 262. AFRICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2025-2032 (USD MILLION)
  • TABLE 263. ASIA-PACIFIC EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 264. ASIA-PACIFIC EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 265. ASIA-PACIFIC EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 266. ASIA-PACIFIC EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 267. ASIA-PACIFIC EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 268. ASIA-PACIFIC EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 269. ASIA-PACIFIC EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 270. ASIA-PACIFIC EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 271. ASIA-PACIFIC EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
  • TABLE 272. ASIA-PACIFIC EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2032 (USD MILLION)
  • TABLE 273. ASIA-PACIFIC EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 274. ASIA-PACIFIC EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 275. ASIA-PACIFIC EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 276. ASIA-PACIFIC EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 277. ASIA-PACIFIC EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2024 (USD MILLION)
  • TABLE 278. ASIA-PACIFIC EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2025-2032 (USD MILLION)
  • TABLE 279. ASIA-PACIFIC EXTRACORPOREAL